Arkolith/Insider Trading/PRAX/Form 4

Kindler Jeffrey B

DirectorPraxis Precision Medicines, Inc. (PRAX) · full profile →Form 4 · filed Feb 10, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 6, 2026Grant(A)478—$01K
Feb 6, 2026Grant(A)688—$0688

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 6, 2026Grant(A)224—$0224

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001689548-26-000017) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML